Efficacy of Arnica D1 Ointment After Upper Blepharoplasty
NCT01598909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136
Last updated 2015-08-25
Summary
Arnica ointment is currently used in homeopathic preparations for strains and bruises. In the field of plastic surgery, some surgeons advise patients undergoing blepharoplasty to use Arnica in order to prevent postoperative ecchymosis, swelling and pain. Thus far, no decent study evaluated the efficacy of topical Arnica ointment in reducing ecchymosis or surgical outcome after upper blepharoplasty. We hypothesize that application of Arnica ointment postoperatively will reduce the development of ecchymosis and improve outcome.
Conditions
- Blepharoplasty
- Upper Eyelid Blepharoplasty
Interventions
- DRUG
-
Arnica
Application of Arnica ointment periorbitally
- DRUG
-
Placebo ointment
Application of Arnica ointment, twice a day, for the period of one week.
Sponsors & Collaborators
-
Wynand BWH Melenhorst, MD
lead OTHER
Principal Investigators
-
W Melenhorst, MD PhD · Isala
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
NCT00407225 ·Status: COMPLETED ·Phase: PHASE2
-
PRevention of Macular EDema After Cataract Surgery
NCT01774474 ·Status: COMPLETED ·Phase: PHASE3
-
Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery
NCT03965078 ·Status: COMPLETED
-
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
NCT00438243 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept
NCT03396861 ·Status: TERMINATED ·Phase: PHASE1
-
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
NCT01124045 ·Status: COMPLETED ·Phase: PHASE3
-
Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)
NCT05331690 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Trial of Dexamethasone Use for Alleviation of Symptoms After Scleral Buckle Eye Surgery
NCT01326585 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy Comparison Study of Steroids to Control Post-operative Inflammation
NCT01801774 ·Status: UNKNOWN ·Phase: PHASE4
-
Confirmatory Study Nepafenac 0.3%
NCT01109173 ·Status: COMPLETED ·Phase: PHASE3
-
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT01591655 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance
NCT04831047 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
NCT04539548 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
NCT00429923 ·Status: COMPLETED ·Phase: PHASE3
-
Nepafenac 0.3% Two Study
NCT01318499 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification
NCT03693989 ·Status: COMPLETED ·Phase: PHASE3
-
PCME Prevention in Patients With NPDR
NCT04940338 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Post op Inflammation After Cataract Surgery
NCT05665270 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
NCT00616993 ·Status: COMPLETED ·Phase: PHASE3
-
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
NCT01298752 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery
NCT00905450 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)
NCT00430092 ·Status: COMPLETED ·Phase: PHASE3
-
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
NCT04977427 ·Status: WITHDRAWN ·Phase: PHASE4
-
IVI Aflibercept Before and After Phaco in DME.
NCT05731089 ·Status: COMPLETED ·Phase: NA
-
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
NCT00469781 ·Status: COMPLETED ·Phase: PHASE4